Agios Pharmaceuticals Inc.

(AGIO) Trade

By |

Profile

Agios Pharmaceuticals Inc is engaged in the development of medicines to treat cancer metabolism and inborn errors of metabolism, which are a subset of orphan genetic metabolic diseases.

Contact Information

Website: www.agios.com
Email: General inquiries: investors@agios.com
Main Phone: +1 617 649-8600
Address: 88 Sidney Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
Employees: 208
NAICS: Pharmaceutical P
$ 85.66 $ -0.79 (-0.91%)
Last Price 85.66 Change $ -0.79 Change % -0.91 Tick N/A
Bid 29.90 Bid Size 100.00 Ask 88.50 Ask Size 1,000.00
Open 85.95 High 86.99 Low 84.19 Prev Close 86.45
Last Trade Volume 346,426 52 Wk Hi 89.33 52 Wk Low 45.11
Market Cap 4.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 57,562,174.00 EPS (TTM) -6.74 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 16 83
Number of Buys 3 26
Number of Sells 13 57
Net Activity 7688 2191
Last 10 Buys Shares
David P. Schenkein 1,000
David P. Schenkein 1,000
David P. Schenkein 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
Marc Tessier-Lavigne 1,000
Last 10 Sell Shares
Lewis C. Cantley 1,000
Lewis C. Cantley 1,000
Lewis C. Cantley 1,000
Lewis C. Cantley 1,000
Lewis C. Cantley 1,000
Lewis C. Cantley 1,000
Lewis C. Cantley 1,000
Lewis C. Cantley 1,000
Scott Biller 1,000
Lewis C. Cantley 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 90 90 90 90
Low Target Price Estimate 47 47 47 47
Mean Target Price Estimate 65.25 64.6 64.6 65.25
Standard Deviation 18.61 16.18 16.18 18.61
Date of Most Recent Estimate 08/05/16 08/05/16 06/17/16 08/05/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 4 4 2
Moderate Buy 0 0 0 0
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.8 1.67 1.67 2.2